Teva Pharmaceutical Industries - 34 Year Stock Price History | TEVA

Historical daily share price chart and data for Teva Pharmaceutical Industries since 1990 adjusted for splits and dividends. The latest closing stock price for Teva Pharmaceutical Industries as of October 31, 2024 is 18.44.
  • The all-time high Teva Pharmaceutical Industries stock closing price was 67.06 on July 27, 2015.
  • The Teva Pharmaceutical Industries 52-week high stock price is 19.08, which is 3.5% above the current share price.
  • The Teva Pharmaceutical Industries 52-week low stock price is 8.54, which is 53.7% below the current share price.
  • The average Teva Pharmaceutical Industries stock price for the last 52 weeks is 14.62.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Teva Pharmaceutical Industries Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 15.5017 10.6700 18.9600 10.6700 18.4400 76.63%
2023 9.1624 9.5300 11.3700 7.2000 10.4400 14.47%
2022 8.6581 8.3300 11.2100 6.8600 9.1200 13.86%
2021 10.0923 10.3400 12.8100 7.9000 8.0100 -16.99%
2020 10.4263 9.5600 13.4500 6.6900 9.6500 -1.53%
2019 11.4964 15.8500 20.0100 6.1600 9.8000 -36.45%
2018 20.9176 19.1100 25.6500 14.5900 15.4200 -18.63%
2017 25.1752 36.2877 36.7524 11.1652 18.9500 -46.01%
2016 48.5120 61.4736 62.0008 33.9156 35.0968 -43.20%
2015 57.4253 51.7518 67.0558 50.5644 61.7937 16.73%
2014 46.9148 36.1043 53.7549 35.7635 52.9393 47.29%
2013 34.4799 32.4379 37.1235 32.4379 35.9429 10.36%
2012 35.9346 36.8548 39.4116 32.2286 32.5688 -5.63%
2011 38.5499 44.2345 47.3106 30.0250 34.5118 -21.23%
2010 46.0024 48.0507 53.7257 39.3724 43.8142 -6.06%
2009 39.9240 35.0590 46.7142 34.0725 46.6394 33.28%
2008 36.8902 38.2007 40.4406 30.9902 34.9932 -7.37%
2007 32.8761 25.2087 38.0625 25.2087 37.7780 50.73%
2006 29.2785 35.2174 35.2174 23.8544 25.0635 -27.08%
2005 26.6383 23.1818 36.3841 21.3405 34.3703 45.04%
2004 23.6841 22.8660 27.1200 18.7397 23.6976 5.76%
2003 20.0211 15.4815 24.2331 13.6685 22.4076 47.25%
2002 12.7675 12.1533 15.5918 10.2099 15.2174 25.60%
2001 11.9083 12.9320 14.3495 9.9910 12.1159 -15.74%
2000 10.4833 6.8561 15.3062 6.2984 14.3787 104.78%
1999 4.7438 4.1278 7.0216 3.8962 7.0216 76.63%
1998 3.9448 4.7305 4.8708 3.1335 3.9754 -13.74%
1997 5.3845 4.8025 6.5470 4.1343 4.6087 -5.58%
1996 4.0556 4.4656 4.8939 2.9571 4.8812 8.70%
1995 3.4050 2.3136 4.5624 2.0783 4.4907 92.58%
1994 2.6080 2.9030 3.2868 2.1614 2.3319 -19.33%
1993 2.3858 2.2125 3.2127 1.7820 2.8905 37.70%
1992 1.3099 1.0536 2.1407 0.9589 2.0991 134.77%
1991 0.7238 0.5536 0.9342 0.5183 0.8941 65.02%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $20.902B $15.846B
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm.
Stock Name Country Market Cap PE Ratio
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.590B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00